Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtronic MAST Opportunities Align With InFuse, Image-Guided Tech

This article was originally published in The Gray Sheet

Executive Summary

Medtronic's spinal unit is emphasizing synergies between minimal access spinal techniques (MAST) and image-guided technology

You may also be interested in...



Medtronic’s $22 Mil. Vertelink Purchase Expands MAST Product Line

Medtronic will pay $22 mil. in cash for all stock of Vertelink Corporation to access the company's Kobra and SST minimal access spine technology (MAST) devices

Medtronic’s $22 Mil. Vertelink Purchase Expands MAST Product Line

Medtronic will pay $22 mil. in cash for all stock of Vertelink Corporation to access the company's Kobra and SST minimal access spine technology (MAST) devices

First Device Qualifies For Add-On Payment; CMS Retains Proposed Threshold

The device industry's hopes to reduce the Centers for Medicare & Medicaid Services' new technology "add-on" payment threshold are riding on a provision in the House's "Medicare Prescription Drug & Modernization Act" of 2003 (HR 1)

UsernamePublicRestriction

Register

OM009163

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel